| Miss Connie M Chesser, MS OTR L | |
|
2401 Gillham Rd, Kansas City, MO 64108-4619 | |
| (816) 234-3380 | |
| (816) 346-1372 |
| Full Name | Miss Connie M Chesser |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 2401 Gillham Rd, Kansas City, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043390602 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Miss Connie M Chesser, MS OTR L 2401 Gillham Rd, Kansas City, MO 64108-4619 Ph: (816) 234-3380 | Miss Connie M Chesser, MS OTR L 2401 Gillham Rd, Kansas City, MO 64108-4619 Ph: (816) 234-3380 |
News Archive
By looking into zinc-finger antiviral proteins (ZAP), a new study from Germany and the United Kingdom (UK) and available on the preprint server bioRxiv suggests that zoonotic transmission of a coronavirus with a specific genetic make-up facilitated the pandemic spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but also its sensitivity to interferons.
In health care reform discussions, talk inevitably turns to making hospitals and physicians accountable for patient outcomes. But in a commentary being published in the July 14 issue of the Journal of the American Medical Association, Johns Hopkins patient safety expert Peter Pronovost, M.D., Ph.D., argues that the health care industry doesn't yet have measurable, achievable and routine ways to prevent patient harm — and that, in many cases, there are too many barriers in the way to attain them.
Having high blood pressure and a particular genetic alteration dramatically increases the risk of heart attack, stroke or death, and may explain why some hypertensive patients fare worse than others - even if they take the same medication, University of Florida researchers announced.
Silence Therapeutics plc announces the issuance of United States patent 7,723,316, titled Compositions and Methods of RNAi Therapeutics For Treatment of Cancer and Other Neovascularization Disease, by the United States Patent and Trademark Office (USPTO).
› Verified 1 days ago
J Gonterwitz, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2400 Pershing Rd, Kansas City, MO 64108 Phone: 816-701-4307 | |
Krista Sue Stalcup, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5703 N Hull Ct, Kansas City, MO 64151 Phone: 816-746-4960 | |
Mrs. Claudia Jean Goldak, OTR L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2401 Gillham Rd, Kansas City, MO 64108 Phone: 816-234-3380 | |
Ms. Sylvia J West, OTR/L,CLT-LANA Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 420 E 80th Ter, Kansas City, MO 64131 Phone: 816-510-3680 | |
Amy Grosenheider, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3101 Main St, Kansas City, MO 64111 Phone: 816-841-2284 | |
Kelly Moberly, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 7326 N Mckinley Ave, Kansas City, MO 64158 Phone: 816-803-6884 | |
Leigh Anne Hatfield, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2000 Ne 46th St, Kansas City, MO 64116 Phone: 816-321-5000 |